Home >
Medicine Info >
Enzictra-DS Tablet
Loading interface...

Enzictra-DS Tablet

Manufactured byALEMBIC LTD
ContainsTrypsin (96 mg) + Rutoside (200 mg) + Bromelain (180 mg) + Papain (120 mg)
Description
Enzictra-DS Tablet is a combination of Trypsin, Rutoside, Bromelain, and Papain. It is used to relieve pain and swelling associated with back pain, arthritis-related pain, sprain, strain, menstrual cramps, post-surgical pain, and headache. This medicine breaks down the proteins involved in pain and swelling and also protects the body from damage by harmful chemical substances. Enzictra-DS Tablet can cause side effects like nausea, vomiting, diarrhoea, and stomach upset. Most of these side effects do not require medical attention and resolve over time. However, if any of these side effects persist or worsen, consult your doctor at the earliest. Enzictra-DS Tablet can be taken with or without food as instructed by your doctor. Your dose and duration of treatment will be decided by your doctor based on your medical condition. Do not skip a dose or double the dose than prescribed. Do not stop the medication on your own without consulting your doctor. Enzictra-DS Tablet is not recommended for use if you are allergic to it. Inform your doctor if you have or have had any medical condition such as problems related to the kidney, liver, blood, etc. Inform your doctor if you are on any medication as it can interact with this medicine and cause side effects. If you are pregnant or breastfeeding, consult your doctor before taking this medicine.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for Enzictra-DS Tablet

  • Nausea or vomiting
  • Stomach upset
  • Diarrhoea
  • Skin rash

Uses of Enzictra-DS Tablet

What is it prescribed for?

  • Pain and inflammation
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time taken by Enzictra-DS Tablet to show its effect is not known.
  • How long do the effects of this medicine last?
    Enzictra-DS Tablet can remain active for 6 to 8 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported for Enzictra-DS Tablet.
  • Can this medicine be taken during pregnancy?
    It is not known whether Enzictra-DS Tablet cause harm to the developing foetus during pregnancy. Hence use this medicine only after consultation with your doctor.
  • Can this medicine be taken while breast-feeding?
    It is not known whether Enzictra-DS Tablet passes into breast milk. Hence consult your doctor before taking this medicine if you are breastfeeding.

Allergy

Enzictra-DS Tablet is not recommended for use if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, swelling and/or itching (especially on your face, lips, throat), breathing difficulty, etc.
Warnings for special population

Pregnancy

It is not known whether Enzictra-DS Tablet cause harm to the developing foetus during pregnancy. Hence use this medicine only after consultation with your doctor.

Breast-feeding

It is not known whether Enzictra-DS Tablet passes into breast milk. Hence consult your doctor before taking this medicine if you are breastfeeding.
General warnings

Driving or operating machines

Enzictra-DS Tablet may rarely cause dizziness, or blurred vision. Hence avoid driving vehicles or operating heavy machines if you experience such symptoms while taking this medicine.

Stool color change

Enzictra-DS Tablet may change the colour and odour of the stool. This is a normal sign and usually not concerning. Consult your doctor if it is worsening or bothering you.

Bleeding

Enzictra-DS Tablet should be taken with caution if you are having or have undergone surgery as it may increase the risk of bleeding during and after surgery. Your doctor may advise you to discontinue this medicine at least two weeks before surgery to avoid bleeding disorders.

Missed Dose

In case the scheduled dose of Enzictra-DS Tablet is missed, make sure that you remember to take your next dose when it is due. Do not take two doses together to make up for a missed dose.

Overdose

Never take more than the prescribed dose of Enzictra-DS Tablet. If you suspect an overdose, consult your doctor for further guidance.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Warfarin

Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take Enzictra-DS Tablet as prescribed by your doctor. Do not crush, break, or chew the tablet in your mouth. Complete the treatment with this medicine for maximum benefits. Do not give your medicine to other people even if their condition appears to be the same as yours. This medicine may change the colour, consistency, and odour of your stool, which is harmless. Inform your doctor if this bothers you.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Effect on sleep is not established

How it works
Enzictra-DS Tablet contains Trypsin, Rutoside, Bromelain, and Papain. Trypsin, Bromelain, and Papain are proteolytic enzymes that help break down proteins involved in swelling and pain. Rutoside is an antioxidant that protects the body from damage by harmful chemical substances and further decreases swelling.
Legal Status

Unknown

Unknown

Unknown

Unknown

Classification

Category

Proteolytic enzyme, Antioxidants, Anti-inflammatory agents

Schedule

Schedule H

Pubchem.ncbi.nlm.nih.gov. 2021. Papain (papaya). [online] Available at: [Accessed 20 April 2021].

https://pubchem.ncbi.nlm.nih.gov/protein/P00784

Pubchem.ncbi.nlm.nih.gov. 2021. Tryptase. [online] Available at: [Accessed 20 April 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Tryptase

Pubchem.ncbi.nlm.nih.gov. 2021. Bromelain. [online] Available at: [Accessed 20 April 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Bromelain

Pubchem.ncbi.nlm.nih.gov. 2021. Rutin. [online] Available at: [Accessed 20 April 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Rutin
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 24 Aug 2022

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.